Literature DB >> 8902193

Loss of function mutations in conserved regions of the human arginase I gene.

J G Vockley1, B K Goodman, D E Tabor, R M Kern, C P Jenkinson, W W Grody, S D Cederbaum.   

Abstract

We have utilized SSCP analysis to identify disease-causing mutations in a cohort with arginase deficiency. Each of the patient's mutations was reconstructed in vitro by site-directed mutagenesis to determine the effect of the mutations on enzyme activity. In addition we identified six areas of cross-species homology in the arginase protein, four containing conserved histidine residues thought to be important to Mn(2+)-dependent enzyme function. Mapping patient mutations in relationship to the conserved regions indicates that substitution mutations within the conserved regions and randomly occurring microdeletions and nonsense mutations have a significant effect on enzymatic function. In vitro mutagenesis was utilized to create nonpatient substitution mutations in the conserved histidine residues to verify their importance to arginase activity. As expected, replacement of histidine residues with other amino acids dramatically reduces arginase activity levels in our bacterial expression system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902193     DOI: 10.1006/bmme.1996.0063

Source DB:  PubMed          Journal:  Biochem Mol Med        ISSN: 1077-3150


  12 in total

1.  Long-term neurodevelopmental effects of early detection and treatment in a 6-year-old patient with argininaemia diagnosed by newborn screening.

Authors:  R L Edwards; K Moseley; Y Watanabe; L J Wong; J Ottina; S Yano
Journal:  J Inherit Metab Dis       Date:  2009-05-27       Impact factor: 4.982

2.  Hyperargininemia: a family with a novel mutation in an unexpected site.

Authors:  Y Haimi Cohen; R Bargal; M Zeigler; T Markus-Eidlitz; V Zuri; A Zeharia
Journal:  JIMD Rep       Date:  2011-12-21

Review 3.  Arginase-1 deficiency.

Authors:  Yuan Yan Sin; Garrett Baron; Andreas Schulze; Colin D Funk
Journal:  J Mol Med (Berl)       Date:  2015-10-14       Impact factor: 4.599

4.  Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response.

Authors:  Luigi Di Costanzo; Guadalupe Sabio; Alfonso Mora; Paulo C Rodriguez; Augusto C Ochoa; Francisco Centeno; David W Christianson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

5.  Neonatal cholestasis: an uncommon presentation of hyperargininemia.

Authors:  Esmeralda Gomes Martins; Ermelinda Santos Silva; Silvia Vilarinho; Jean Marie Saudubray; Laura Vilarinho
Journal:  J Inherit Metab Dis       Date:  2011-01-13       Impact factor: 4.982

Review 6.  Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency.

Authors:  Fernando Scaglia; Brendan Lee
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

Review 7.  The human arginases and arginase deficiency.

Authors:  R Iyer; C P Jenkinson; J G Vockley; R M Kern; W W Grody; S Cederbaum
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

8.  Mouse model for human arginase deficiency.

Authors:  Ramaswamy K Iyer; Paul K Yoo; Rita M Kern; Nora Rozengurt; Rosemarie Tsoa; William E O'Brien; Hong Yu; Wayne W Grody; Stephen D Cederbaum
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

9.  Prenatal diagnosis for arginase deficiency: a case study.

Authors:  S Hewson; J T R Clarke; S Cederbaum
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 10.  Contrasting features of urea cycle disorders in human patients and knockout mouse models.

Authors:  Joshua L Deignan; Stephen D Cederbaum; Wayne W Grody
Journal:  Mol Genet Metab       Date:  2007-10-22       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.